Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LogicBio Therapeutics, Inc. | President, CEO, Director | Common Stock | 0 | $2.01 | Nov 16, 2022 | Direct | |
LogicBio Therapeutics, Inc. | President, CEO, Director | Stock Option (right to buy) | 0 | Nov 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LOGC | LogicBio Therapeutics, Inc. | Nov 16, 2022 | 3 | $0 | 4 | Nov 17, 2022 | President, CEO, Director |
LOGC | LogicBio Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 3, 2022 | President and Chief Executive, Director |